Lovastatin monotherapy has been reported to have been a cause of rhabdomyolysis, acute renal failure and hepatopathy. - GreenMedInfo Summary
Rhabdomyolysis, acute renal failure and hepatopathy induced by lovastatin monotherapy.
Jpn Heart J. 1997 Jul ;38(4):541-5. PMID: 9350151
Department of Internal Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan.
Lovastatin is a popular drug for the treatment of hypercholesterolemia. Few serious complications are associated with its use although rhabdomyolysis with renal failure has been reported when lovastatin is combined with cyclosporine or other drugs following transplantation. We report the case of a patient who developed hepatopathy and rhabdomyolysis accompanied by acute renal failure after 4 weeks of lovastatin monotherapy. The pathogenesis and treatment of these complications are also discussed.